Get started
Author

Heli Eronen

Observed names: Eronen, Heli, H Eronen
ORCID: 0000-0003-1504-5642
Observed ORCID: 0000-0003-1504-5642
OpenAlex ID: A5029695110
Combining biological therapies in patients with inflammatory bowel disease: a Finnish multi-centre study
2022 · Heli Eronen, Sara Kolehmainen, et al. · Scandinavian Journal of Gastroenterology · 31
PDF
Steroid hormone receptors and coregulators in endocrine‐resistant and estrogen‐independent breast cancer cells
2005 · Nanna Sarvilinna, Heli Eronen, et al. · International Journal of Cancer · 28
PDF
Long-term outcome of patients with acute ulcerative colitis after first course of intravenous corticosteroids
2021 · Heli Eronen, Tuire Ilus, et al. · Scandinavian Journal of Gastroenterology · 13
PDF
Tofacitinib real-world experience in ulcerative colitis in Finland (FinTofUC): a retrospective non-interventional multicenter patient chart data study
2023 · Pauliina Molander, Mikko Kosunen, et al. · Scandinavian Journal of Gastroenterology · 6
PDF
Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study
2025 · Pauliina Molander, Clas-Göran af Björkesten, et al. · European Journal of Gastroenterology & Hepatology · 5
Long-term outcomes of patients with acute severe ulcerative colitis treated with cyclosporine rescue therapy
2022 · Heli Eronen, Pia Oksanen, et al. · Scandinavian Journal of Gastroenterology · 5
Biologisten lääkkeiden yhdistelmähoito tulehduksellisissa suolistosairauksissa
2023 · Eronen, Heli, Molander, Pauliina · Työväentutkimus Vuosikirja
PDF
Persistent abdominal pain in kidney transplant recipient
2022 · Iivo Hetemäki, Heli Eronen, et al. · American Journal of Transplantation
P742 Long-term outcome of patients with ulcerative colitis and first course of intravenous corticosteroids
2018 · H Eronen, P Oksanen, et al. · Journal of Crohn s and Colitis
Works count: 10
Citation count: 88
H-index: 5
I10-index: 3
Year
Topic
Type